Oculopharyngeal muscular dystrophy (OPMD) is a genetic disorder that affects the muscles of the eyes and throat. It is characterized by progressive weakness and wasting of these muscles, leading to difficulties with swallowing, speaking, and controlling eye movements. OPMD typically starts in adulthood, usually between the ages of 40 and 60, and can vary widely in intensity between individuals. It is caused by changes in genes that are involved in muscle function. Treatment for OPMD focuses on managing symptoms and improving quality of life. This may include speech therapy to improve swallowing and communication, dietary changes to make swallowing easier, and assistive devices such as special utensils or feeding tubes if swallowing becomes very difficult. While there is currently no cure for OPMD, ongoing research may lead to new treatments in the future.

What is "oculopharyngeal muscular dystrophy"?

394cbdf365ae209b8960eac6be7c413321bea86283c43b1c32a62cc98edbaf9d

oculopharyngeal muscular dystrophy

https://tts.langeek.co/read?text=b2N1bG9waGFyeW5nZWFsIG11c2N1bGFyIGR5c3Ryb3BoeQ&hash=fda142cbf4a9de776308b5b5162cb7ff5b9d458b&lang=en&cache-only=0&driver=googletts&accent=US

https://tts.langeek.co/read?text=b2N1bG9waGFyeW5nZWFsIG11c2N1bGFyIGR5c3Ryb3BoeQ&hash=8b7effaeb9bfb631b35daeca9513f1a38282a81b&lang=en&cache-only=0&driver=googletts&accent=GB

英語での「oculopharyngeal muscular dystrophy」の定義と意味

Download Mobile App